MARC record from Internet Archive

LEADER: 04586cam 2200781 a 4500
001 ocm38099903
003 OCoLC
005 20200519194252.0
008 980319s1998 paua b 001 0 eng d
040 $aVAM$beng$cNLM$dVAM$dMMU$dIWA$dBAKER$dNLGGC$dCGC$dDRB$dAU@$dEYM$dGEBAY$dOCLCF$dDEBBG$dWVU$dOCLCO$dOCLCQ$dOCLCO$dNLM$dOCLCO$dOCLCA$dUKMGB$dOCLCA
016 7 $a9801200$2DNLM
016 7 $a010215181$2Uk
016 7 $a006424007$2Uk
020 $a9780397518487
020 $a039751848X
035 $a(OCoLC)38099903
050 4 $aRM322$b.A58 1998
060 00 $aW1$bAD684H v.76 1998
060 10 $aQV 85$bA6273 1998
082 04 $a616.853061$221
084 $a44.90$2bcl
084 $aXI 5405$2rvk
084 $aYG 1605$2rvk
084 $aHE 92$2blsrissc
245 00 $aAntiepileptic drug development /$ceditors, Jacqueline A. French, Marc A. Dichter, Ilo E. Leppik.
260 $aPhiladelphia, Pa. :$bLippincott-Raven Publishers,$c1998.
300 $axvii, 276 pages :$billustrations.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aAdvances in neurology,$x0091-3952 ;$vv. 76
504 $aIncludes bibliographical references and index.
505 0 $aMechanism of action of new antiepileptic drugs -- Mechanism-specific pathways for new antiepileptic drug discovery -- National Institutes of Health anticonvulsant drug development program: screening for efficacy -- Pharmaceutical industry screening for new antiepileptic drugs -- Metabolic enzymes and antiepileptic drug interactions -- New drugs for persons with epilepsy -- AED doses: from animals to humans -- Assessing pharmacokinetic and pharmacodynamic drug interactions in clinical trials of antiepileptic drugs -- Novel methods for studying new antiepileptic drug pharmacology -- Art of antiepileptic trial design -- Reanalysis of existing trial data: what can be learned -- Monotherapy trials -- Impact of foreign data on a new drug application -- Issues for women in antiepileptic drug development -- Antiepileptic drug trials in children and adolescents: is there a need? -- Pediatric trials: practical issues. Special populations and trial design -- Clinical trials for status epilepticus -- Clinical trials for seizure prevention -- Alternate endpoints for seizure measurement -- Alternate endpoints: studies in quality of life and health economics of epilepsy -- Alternate endpoint: EEG assessment of antiepileptic drug efficacy and toxicity -- Routine measurement of new antiepileptic drug concentrations: a critique and a prediction -- Cognitive and behavioral assessments in AED trials -- Economic factors in the development of new antiepileptic drugs -- Recent issues and considerations in the regulation of antiepileptic drugs -- Ethical and institutional review board issues -- Postmarketing studies.
650 0 $aAnticonvulsants.
650 0 $aEpilepsy$xChemotherapy.
650 12 $aAnticonvulsants$xpharmacology.
650 22 $aClinical Trials as Topic$xmethods.
650 22 $aDrug Evaluation, Preclinical$xmethods.
650 22 $aEpilepsy$xdrug therapy.
650 22 $aResearch Design.
650 7 $aAnticonvulsants.$2fast$0(OCoLC)fst00810472
650 7 $aEpilepsy$xChemotherapy.$2fast$0(OCoLC)fst00914186
650 7 $aAntiepileptikum$2gnd
650 7 $aArzneimittelentwicklung$2gnd
650 7 $aKongress$2gnd
650 7 $aAufsatzsammlung$2gnd
650 17 $aAnti-epileptica.$2gtt
655 4 $aAufsatzsammlung.
655 4 $aKongre©$zCharleston (SC)$y1996.
655 7 $aAufsatzsammlung.$0(DE-588)4143413-4.$2gnd
655 7 $aKonferenzschrift$y1996$zCharleston SC.$0(DE-588)1071861417.$2gnd
700 1 $aFrench, Jacqueline A.
700 1 $aDichter, Marc A.
700 1 $aLeppik, Ilo E.
776 08 $iOnline version:$tAntiepileptic drug development.$dPhiladelphia, Pa. : Lippincott-Raven Publishers, 1998$w(OCoLC)609831076
830 0 $aAdvances in neurology ;$vv. 76.
856 41 $3Table of contents$uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007988510&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
938 $aBaker & Taylor$bBKTY$c145.00$d145.00$i039751848X$n0003102015$sactive
029 0 $aNLM$b9801200
029 1 $aAU@$b000013655845
029 1 $aDEBBG$bBV011829972
029 1 $aGEBAY$b2809201
029 1 $aNLGGC$b165588551
029 1 $aNZ1$b3727391
029 1 $aUKMGB$b010215181
029 1 $aUKMGB$b006424007
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 141 OTHER HOLDINGS